Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

25.39
Delayed Data
As of Dec 06
 +1.79 / +7.58%
Today’s Change
6.66
Today|||52-Week Range
37.69
+147.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization725.0K641.0K603.0K197.0K
 
 
 
 
 
 
Operating ExpensesGross Income-----603.0K-197.0K
 
 
 
General Expenses18.6M20.5M19.2M19.6M
 
 
 
 
 
Research And Development12.5M14.3M14.2M13.4M
 
 
 
 
 
Total Operating Expenses19.3M21.1M19.8M19.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-19.3M-21.1M-19.8M-19.8M
 
 
 
 
 
Extraordinary Credit0.001.2M5.1M1.0M
 
 
 
 
Extraordinary Charge-1.5M0.000.000.00
 
 
Other Expenses80.0K546.0K531.0K-2.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.7M-19.3M-14.1M-18.7M
 
 
 
 
 
Income Taxes-18.0K-15.0K-26.0K-29.0K
 
 
 
 
 
Net Income-20.7M-19.3M-14.1M-18.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS362.8K521.7K713.5K1.4M
 
 
 
 
 
Shares To Calculate EPS Diluted362.8K521.7K713.5K1.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$57.30-$37.20-$19.80-$13.80
 
 
 
 
 
EPS Diluted-$57.30-$37.20-$19.80-$13.80